Announcing Causaly Connect: A virtual meeting of Life Science leaders
On October 4-6, Life Science professionals from across the globe will meet virtually for Causaly Connect – an insightful series of...
Why poor target validation is costing pharmaceutical businesses millions
It has been well documented that only 1 out of 10 compounds that enter clinical trials makes it to market¹. That is an astonishing 90%...
- Point of View
Watch Causaly’s panel discussion from Discovery Europe
On June 9th – 10th 2022, over 400 pharma leaders came to Berlin to take part in Discovery Europe...
- General
Webinar - Knowledge discovery reimagined: finding new hypotheses with Causaly Cloud
It is well recognized among scientists that target selection can improve clinical trial success rates (1). Being able to stay up to date...
- use case